Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001698530-25-000085
Filing Date
2025-09-23
Accepted
2025-09-23 16:07:41
Documents
18
Period of Report
2025-09-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A xcur-20250923.htm   iXBRL DEF 14A 361274
6 xcur-20250923_g1.jpg GRAPHIC 170008
7 xcur-20250923_g2.jpg GRAPHIC 455245
8 xcur-20250923_g3.jpg GRAPHIC 194771
  Complete submission text file 0001698530-25-000085.txt   2654687

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250923.xsd EX-101.SCH 2789
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20250923_def.xml EX-101.DEF 3363
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250923_lab.xml EX-101.LAB 3829
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250923_pre.xml EX-101.PRE 2396
20 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250923_htm.xml XML 41917
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39011 | Film No.: 251333702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)